Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 1035Neoplasms 813Carcinoma, Non-Small-Cell Lung 796Prostatic Neoplasms 617Colorectal Neoplasms 533Lung Neoplasms 478Neoplasm Metastasis 434Multiple Myeloma 394Leukemia, Myeloid, Acute 380Ovarian Neoplasms 333Pancreatic Neoplasms 316Melanoma 293Squamous Cell Carcinoma of Head and Neck 266Recurrence 260Carcinoma, Hepatocellular 248Glioblastoma 237Brain Neoplasms 236Triple Negative Breast Neoplasms 213Head and Neck Neoplasms 210Carcinoma, Renal Cell 207Precursor Cell Lymphoblastic Leukemia-Lymphoma 203Lymphoma 198Stomach Neoplasms 197Endometrial Neoplasms 190Uterine Cervical Neoplasms 182Lymphoma, Non-Hodgkin 182Sarcoma 180Glioma 179Lymphoma, Large B-Cell, Diffuse 166Hematologic Neoplasms 162

Interventions

durvalumab 1Gemcitabine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Locally Advanced or Metastatic Solid Tumours × 90 days × Clear all
NCT04999969 2026-04-30

Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours

AstraZeneca

Phase 2 Active not recruiting
126 enrolled 30 charts
Other solid neoplasm

Locally Advanced or Metastatic Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡